Journal Mobile Options

Vol. 30, No. 4, 2012

Issue release date: July 2012

Revisiting IBD Management: Dogmas to Be Challenged

Falk Symposium 179, Brussels, September-October 2011

See also ISBN 978-3-318-02185-1 for more details
Select / Unselect all
325

Title Page / Table of Contents

Dig Dis 2012;30:325–328 (DOI:10.1159/000339700)
Free Access
Introduction
329

Challenging Dogmas in IBD

D’Haens G.
Dig Dis 2012;30:329 (DOI:10.1159/000338403)
Free Access
IBD Is a Disorder of Defective Autophagy and Innate Immunity
330

Evidence from Genetics for a Role of Autophagy and Innate Immunity in IBD Pathogenesis

Parkes M.
Dig Dis 2012;30:330–333 (DOI:10.1159/000338119)
334

Commensal-Innate Immune Miscommunication in IBD Pathogenesis

Cario E.
Dig Dis 2012;30:334–340 (DOI:10.1159/000338120)
341

Endoplasmic Reticulum Stress and Inflammation

Adolph T.-E. · Niederreiter L. · Blumberg R.S. · Kaser A.
Dig Dis 2012;30:341–346 (DOI:10.1159/000338121)
Free Access
No Bacteria, No IBD
347

Lessons from Diversion Studies and Antibacterial Interventions

Flanagan P.K. · Campbell B.J. · Rhodes J.M.
Dig Dis 2012;30:347–350 (DOI:10.1159/000338122)
351

Bacteriology in the Etiopathogenesis of Pouchitis

Shen B.
Dig Dis 2012;30:351–357 (DOI:10.1159/000338125)
358

The Role of Anti(myco)bacterial Interventions in the Management of IBD: Is There Evidence at All?

Pineton de Chambrun G.P. · Torres J. · Darfeuille-Michaud A. · Colombel J.-F.
Dig Dis 2012;30:358–367 (DOI:10.1159/000338126)
Steroids Are Useful for the Management of IBD
368

Second-Generation Corticosteroids for the Treatment of Crohn’s Disease and Ulcerative Colitis: More Effective and Less Side Effects?

De Cassan C. · Fiorino G. · Danese S.
Dig Dis 2012;30:368–375 (DOI:10.1159/000338128)
Early and Late Crohn’s Disease Are Distinct Entities
376

Epidemiology of the Transition from Early to Late Crohn’s Disease

Louis E.
Dig Dis 2012;30:376–379 (DOI:10.1159/000338129)
380

Markers That Differentiate Early from Late IBD

Huang C. · Kugathasan S.
Dig Dis 2012;30:380–382 (DOI:10.1159/000338130)
Innovative Treatments Will Offer a Better Outcome for Patients with IBD
383

Biologic Therapies: Lessons from Multiple Sclerosis

Ghosh S.
Dig Dis 2012;30:383–386 (DOI:10.1159/000338131)
387

Current Status of Mesenchymal Stem Cell Therapy and Bone Marrow Transplantation in IBD

Ricart E.
Dig Dis 2012;30:387–391 (DOI:10.1159/000338134)
392

Reprogramming the Immune System in IBD

MacDonald T.T. · Vossenkaemper A. · Fantini M. · Monteleone G.
Dig Dis 2012;30:392–395 (DOI:10.1159/000338136)
Patient-Tailored Therapies Are Superior to Algorithmic Approaches in IBD
396

How to Guide Therapeutic Decisions in a Patient-Tailored Approach to Treatment of IBD?

Rutgeerts P.
Dig Dis 2012;30:396–399 (DOI:10.1159/000338137)
400

Treat the Patient or Treat the Disease?

Hanauer S.B. · Kirsner J.B.
Dig Dis 2012;30:400–403 (DOI:10.1159/000338139)
Immunosuppression Puts IBD Patients at Risk for Severe Complications
404

Combined Immunosuppression Is More Dangerous than Monotherapy: What Is Fact and What Is Fiction?

Schölmerich J.
Dig Dis 2012;30:404–407 (DOI:10.1159/000338140)
408

Prevention and Management of Infectious Complications in IBD

Rahier J.-F.
Dig Dis 2012;30:408–414 (DOI:10.1159/000338143)
415

Immunosuppression-Related Lymphomas and Cancers in IBD: How Can They Be Prevented?

Beaugerie L.
Dig Dis 2012;30:415–419 (DOI:10.1159/000338144)
420

How to Manage IBD in Patients with Infections or Malignancies?

Kohn A. · Meddi P.
Dig Dis 2012;30:420–424 (DOI:10.1159/000338145)
Leaving the Dogmas Behind and Looking into the Future
425

Towards a Novel Molecular Classification of IBD

Vermeire S.
Dig Dis 2012;30:425–427 (DOI:10.1159/000338147)
428

Towards a ‘Cure’ for IBD

Fiocchi C.
Dig Dis 2012;30:428–433 (DOI:10.1159/000338148)
 
434

Falk Symposium Series

Dig Dis 2012;30:434–436 (DOI:10.1159/000339699)
Free Access
437

Author Index Vol. 30, No. 4, 2012

Dig Dis 2012;30:437 (DOI:10.1159/000339701)
Free Access
438

Subject Index Vol. 30, No. 4, 2012

Dig Dis 2012;30:438 (DOI:10.1159/000338421)
Free Access